by Jordana Choucair | Nov 8, 2021 | Life Sciences
Regeneron Pharmaceuticals Inc. said its COVID-19 antibody cocktail offered long-term protection to patients in a late-stage trial. According to the drug manufacturer, there were no hospitalizations for COVID-19 in the REGEN-COV group during the eight-month assessment...
by Jordana Choucair | Nov 5, 2021 | D.C. News
The Biden administration set a January 4 deadline for its private-sector vaccine mandate. However, all unvaccinated workers must start wearing masks indoors a month earlier on December 5. The regulations are aimed at health care workers and businesses with 100 or more...
by Jordana Choucair | Nov 5, 2021 | Payers
Senators Mike Braun and Tammy Baldwin reintroduced bipartisan legislation that aims to ensure more affordable contracts between payers and providers. The Healthy Competition for Better Care Act would prohibit requirements for payers to contract with affiliated...
by Jordana Choucair | Nov 5, 2021 | Life Sciences
The U.S. canceled a $600 million deal with Emergent BioSolutions, the vaccine manufacturer that ruined millions of Johnson & Johnson COVID-19 doses. The cancellation comes after Emergent’s manufacturing facilities in Baltimore were found to have produced millions...
by Jordana Choucair | Nov 5, 2021 | Life Sciences
Pfizer announced that its antiviral COVID-19 pill cut the risk of hospitalizations and deaths by 89 percent compared to those who received a placebo. The pharmaceutical company reported that three of the 389 people who received the drug (0.8 percent) were hospitalized...
Recent Comments